Atlas Trials

Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome

Clinical trial NCT05012228 · UNKNOWN

Trial details

NCT number
NCT05012228
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Renal Fibrosis, CKD
Start date
2021-07-01
Primary completion
2022-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.